We are live on
!
Find out more
GT
Glenmede Trust Portfolio holdings
AUM
$20.4B
This Fund
S&P 500
This Quarter
Est. Return
+23.43%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$16.4B
AUM Growth
-$5.58B
(-25%)
Cap. Flow
-$3.87B
Cap. Flow
% of AUM
-23.65%
Top 10 Holdings %
Top 10 Hldgs %
18.07%
Holding
3,458
New
283
Increased
974
Reduced
1,077
Closed
907
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$97.1M |
| 2 |
iShares Core S&P Small-Cap ETF
IJR
|
+$76.6M |
| 3 |
Lowe's Companies
LOW
|
+$75.4M |
| 4 |
Monster Beverage
MNST
|
+$64.6M |
| 5 |
FISV
Fiserv Inc
FISV
|
+$63.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Accenture
ACN
|
+$114M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$109M |
| 3 |
Trane Technologies
TT
|
+$106M |
| 4 |
Microsoft
MSFT
|
+$104M |
| 5 |
Mastercard
MA
|
+$104M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.03% |
| 2 | Healthcare | 13.89% |
| 3 | Financials | 11.27% |
| 4 | Consumer Discretionary | 8.92% |
| 5 | Industrials | 8.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1051
Healthcare Realty
HR
$7.56B
| $167K | ﹤0.01% |
6,320
-1,875
| -23% | -$48K |
|
1052
Dentsply Sirona
XRAY
$2.84B
| $167K | ﹤0.01% |
3,812
-719
| -16% | -$30.4K |
|
1053
Vornado Realty Trust
VNO
$7.65B
| $166K | ﹤0.01% |
4,367
+1,484
| +51% | +$57.6K |
|
1054
Zoom
ZM
$27.1B
| $166K | ﹤0.01% |
+659
| New | +$119K |
|
|
RETA
1055
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $165K | ﹤0.01% |
1,062
-673
| -39% | -$102K |
|
1056
Brady Corp
BRC
$4.46B
| $164K | ﹤0.01% |
3,518
-438
| -11% | -$20.1K |
|
1057
Huron Consulting
HURN
$2.76B
| $164K | ﹤0.01% |
3,708
+209
| +6% | +$9.42K |
|
1058
Regions Financial
RF
$26.4B
| $163K | ﹤0.01% |
14,730
-1,647
| -10% | -$17.5K |
|
1059
ProShares S&P 500 Dividend Aristocrats ETF
NOBL
$11.9B
| $162K | ﹤0.01% |
4,850
| – | – |
|
1060
Omega Flex
OFLX
$292M
| $161K | ﹤0.01% |
1,525
+1,040
| +214% | +$98.9K |
|
1061
MongoDB
MDB
$25.8B
| $159K | ﹤0.01% |
706
+295
| +72% | +$54.6K |
|
1062
Stepan Co
SCL
$1.5B
| $159K | ﹤0.01% |
1,646
+111
| +7% | +$10.4K |
|
1063
Monro
MNRO
$414M
| $156K | ﹤0.01% |
2,850
-2,975
| -51% | -$158K |
|
|
MODN
1064
DELISTED
MODEL N, INC.
MODN
| $156K | ﹤0.01% |
+4,505
| New | +$131K |
|
1065
El Paso Energy Capital Trust I
EP.PRC
$222M
| $155K | ﹤0.01% |
3,500
-265
| -7% | -$12.2K |
|
1066
Healthcare Services Group
HCSG
$1.61B
| $154K | ﹤0.01% |
6,300
| – | – |
|
1067
NiSource
NI
$21.5B
| $153K | ﹤0.01% |
6,746
+189
| +3% | +$4.56K |
|
1068
Takeda Pharmaceutical
TAK
$56.7B
| $153K | ﹤0.01% |
8,580
-2,170
| -20% | -$39K |
|
1069
FRP Holdings
FRPH
$439M
| $152K | ﹤0.01% |
7,500
| – | – |
|
1070
LendingTree
TREE
$551M
| $152K | ﹤0.01% |
+528
| New | +$128K |
|
|
RP
1071
DELISTED
RealPage, Inc.
RP
| $149K | ﹤0.01% |
2,295
+2,210
| +2,600% | +$139K |
|
1072
Cabot Corp
CBT
$4.72B
| $148K | ﹤0.01% |
4,000
-73
| -2% | -$2.44K |
|
1073
Magna International
MGA
$18.8B
| $148K | ﹤0.01% |
3,342
-4,961
| -60% | -$196K |
|
1074
Marvell Technology
MRVL
$147B
| $148K | ﹤0.01% |
4,239
+2,039
| +93% | +$59.7K |
|
1075
Sally Beauty Holdings
SBH
$1.47B
| $148K | ﹤0.01% |
11,888
+113
| +1% | +$1.24K |
|
Similar funds
EWA
MIC
P
OSAM
CB
EIM
SC
Glenmede Trust's Q2 2020 Portfolio in Review
As of Q2 2020, Glenmede Trust held 3,458 positions worth $16.4B, down 25% from $21.9B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Glenmede Trust withdrew a net $3.87B in Q2 2020, closing 907 positions and reducing 1,077 holdings. Its most notable exit was Raytheon Company, an estimated $66.5M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 19% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Glenmede Trust opened a new position in Carrier Global worth $21.3M.
- Glenmede Trust's largest Q2 2020 buy was Carrier Global: 960,042 shares worth $21.3M.
- Glenmede Trust added most to State Street SPDR S&P 500 ETF Trust in Q2 2020, an estimated $97.1M increase.
- Glenmede Trust's biggest Q2 2020 reduction was Accenture, cutting an estimated $114M.
- Glenmede Trust fully exited Raytheon Company in Q2 2020, selling an estimated $66.5M.
- Glenmede Trust's ten largest holdings make up 18% of its $16.4B portfolio in Q2 2020.
- Glenmede Trust opened 283 new positions and closed 907 in Q2 2020.
- Glenmede Trust's portfolio value fell 25% quarter-over-quarter to $16.4B.
Based on Glenmede Trust's 13F filing for Q2 2020, filed 14 Aug 2020.